We present a method for handling dose constraints as part of a convex programming framework for inverse treatment planning. Our method uniformly handles mean dose, maximum dose, minimum dose, and dose-volume (i.e., percentile) constraints as part of a convex formulation. Since dose-volume constraints are non-convex, we replace them with a convex restriction. This restriction is, by definition, conservative; to mitigate its impact on the clinical objectives, we develop a two-pass planning algorithm that allows each dose-volume constraint to be met exactly on a second pass by the solver if its corresponding restriction is feasible on the first pass. In another variant, we add slack variables to each dose constraint to prevent the problem from becoming infeasible when the user specifies an incompatible set of constraints or when the constraints are made infeasible by our restriction. Finally, we introduce ConRad, a Python-embedded opensource software package for convex radiation treatment planning. ConRad implements the methods described above and allows users to construct and plan cases through a simple interface.
Introduction
External beam radiation therapy is the treatment of diseased tissue with beams of ionizing radiation delivered from a source outside the patient. When radiation passes through the patient, it damages both healthy and diseased tissue. A treatment plan must be carefully designed to minimize harm to healthy organs, while delivering enough dose to ablate the targeted tissue. With recent hardware advances, delivered beams can be positioned and shaped with growing sophistication, and clinicians rely increasingly on optimization techniques to guide their treatment decisions. In this paper, we focus on one part of the treatment planning process: the selection of an optimal intensity profile for every radiation beam.
In [SFOM99] , the authors provide a comprehensive survey of several problem formulations for treatment planning, including linear [RLMB91] [Höl03] and quadratic programming models [JBBS90, XC96, XHS
+ 98]. Generally, linear models minimize the weighted sum of doses or the maximum deviation from a prescribed dose, while quadratic models minimize the weighted sum of squared difference between actual and prescribed dose. These formulations incorporate linear bounds on the dose to each structure. Solutions can be rapidly found using various interior point methods, such as primal-dual [AGRD10] , projected gradient [AMS13] , and interior point constraint generation [OGTA11] .
To address conflicting clinical goals, researchers have proposed models with multiple objectives and constraints. By varying the weight on each objective, one can produce a set of solutions on the Pareto frontier [HK02] [HCB06a] . A large number of treatment evaluation criteria can be transformed into convex criteria within this framework [RDL04] . Although multi-objective optimization offers flexibility, calculating thousands of points on the Pareto frontier proves computationally inefficient in practice, and expert judgment is still required to select a clinically acceptable plan from the set of mathematically optimal plans.
All the methods discussed so far hinge on a convex problem formulation. However, many clinically relevant constraints are non-convex. One such type is the dose-volume constraint, which bounds the dose delivered to a given percentage of a patient's anatomy [ZLL + 14] . A review of some models for handling this class of constraints is given in [EGHS08] . The simplest approach is to add a nonlinear, volume-sensitive penalty to the objective function [ [MM93] , is used to solve the optimization problem. Unfortunately, since this formulation is non-convex, these algorithms often produce a local minimum, resulting in a sub-optimal treatment plan [Dea97] [WM02]. Another method is to directly model the dose-volume constraint with a set of binary decision variables. Each variable indicates whether a voxel should be included in the fraction of a structure's volume that must fulfill the dose bound [LBU + 90] [LFC00] [LFC03] . Given the dimensions of patient data, this results in a large-scale mixed-integer programming problem, which is prohibitively expensive to compute for most clinical cases.
A more promising approach is to replace each dose-volume constraint with a convex approximation. This allows users to take advantage of large-scale convex optimization algorithms to quickly generate treatment plans. For instance, [HCB06b] substitutes a ramp function for the indicator that a particular voxel violates its desired dose-volume threshold, then penalizes the total number of voxel violations in the objective. Other researchers have employed the conditional value-at-risk (CVaR), a metric that represents the average tail loss in a probability distribution [RU00] . It is convex in the loss variable and thus offers a computationally suitable alternative to the dose-volume constraint. In the recent literature, CVaR has been used to formulate linear constraints on the average dose in the upper and lower tails of a structure's dose distribution, leading to significant improvements in treatment plans [RAD
. However, CVaR functions are parametric, and implementations of this model require a heuristic search over the parameter space to obtain a good approximation of the dose-volume constraint [AGS + 10]. Perhaps the method most similar to ours is [ZST + 13]. In this paper, the authors propose constraining the dose moments to equal those of the desired dose-volume histogram curve.
They derive a convex relaxation of these constraints, then solve their treatment planning problem in two phases: the first phase adds slack variables to the moment bounds, so a solution is always feasible, while the second phase tightens these bounds in order to improve upon plan quality whenever possible. Using only three moments, their technique is able to closely match the reference histogram curves in a prostate cancer case.
These results demonstrate the power of convex models: they provide more flexibility than linear or quadratic models, while avoiding the issue of multiple local optima in nonconvex formulations and the intractability of a mixed-integer program. In this paper, we propose a new convex formulation of the fluence map optimization problem with dose-volume constraints. Given a predetermined number of candidate beams, we construct a convex optimization problem around a set of clinical goals and solve for the radiation intensity pattern that best achieves these goals subject to restrictions on the dose distribution. Our algorithm is quick and efficient, allowing clinicians to rapidly compare trade-offs between different plans and select the best treatment for a patient. We provide a Python package, ConRad, that implements our method within a simple intuitive interface.
This paper is organized as follows: In Sect. 2, we review the radiation treatment planning problem. In Sect. 3, we describe the patient characteristics and constraints that clinicians must consider when selecting an optimal plan. In Sect. 4, we define a convex optimization framework for the basic treatment planning problem. Sect. 5 introduces dose constraints. We show how to incorporate dose-volume constraints via a convex restriction, which provides an approximation of the dose percentile. In Sect. 6, we present two extensions to our model. Sect. 7 describes the Python implementation of our algorithm, and Sect. 8 demonstrates its performance in several clinical cases. Finally, Sect. 9 concludes.
Problem Description
During external beam radiation therapy, ionizing radiation travels through a patient, depositing energy along the beam paths. Radiation damages both diseased and healthy tissue, but clinicians aim to damage these tissues differentially, exploiting the fact that cancer cells typically have faulty cell repair mechanisms and exhibit a lower tolerance to radiation than healthy cells. The goal is to focus radiation beams such that enough dose is delivered to kill diseased tissue, while avoiding as much of the surrounding healthy organs as possible. The clinician separates these structures into one or more planning target volumes (PTVs) to be irradiated at a prescribed dose level and several organs-at-risk (OARs) to spare from radiation.
Before treatment, the patient is positioned on a couch. Photon, electron, proton, or heavier particle beams are generated with a particle accelerator and coupled to a mechanized gantry that contains additional hardware components, which shape and focus the beams. The gantry typically rotates around one central axis (but may have additional rotational and translational degrees of freedom [MHS
, so that by controlling the gantry and couch, beams can be delivered from almost any angle and location around the patient.
Delivery strategies vary from using a large number of apertures (beam shapes) delivered sequentially from a few beam angles, as in intensity-modulated radiation therapy (IMRT), to calculating a single optimal aperture at a large number of angles, as in volumetric modulated arc therapy (VMAT). For a given delivery strategy, the goal of treatment planning is to determine the optimal beam angles, shapes and intensities that most closely approximate a desired dose distribution to the targeted volumes. In this work, we consider the task of optimizing intensities for a given set of beams of known positions and shapes, i.e., calculating optimal beam weights. This is applicable to the fluence map optimization (FMO) step in IMRT planning, the FMO step in direct aperture optimization for modalities such as VMAT, 4π, or SPORT [Bed09] 3 Clinical Planning
Dose Physics
Prior to treatment, medical images-such as CT, MRI and PET scans-are collected to form a three-dimensional image of the patient's anatomy. This representation is discretized into regular volume elements, or voxels. The anatomy is then delineated by clinicians into various structures, and the dose to each structure is considered during planning. Although the structure contours drawn by clinicians may overlap, in this work, we associate each voxel with a single structure. Dose calculation algorithms range from analytical approximations to Monte Carlo simulations, but in all cases, they provide a model with a linear mapping from beam intensities to delivered voxel doses. The dose within each voxel is assumed to be uniform. For each candidate beam, we have an aperture shape that may be further subdivided, e.g., into regular rectangular subdivisions called beamlets. The intensities of these beams (or beamlets) are represented in a vector. A patient-specific dose deposition matrix maps this vector of radiation intensities to the vector of doses delivered per voxel.
Dose Objectives
Given a fixed number of candidate beams, our goal is to determine the beam intensities that satisfy a clinical objective defined in terms of the dose delivered to each voxel in the patient anatomy.
Every PTV is prescribed a desired dose, which we wish to deposit uniformly throughout the target. Delivering too high or too low a dose of radiation has different clinical consequences, so we introduce separate underdose and overdose penalties for every PTV. In the case of OARs, a lower dose is always preferable, so we penalize any dose above zero and omit an underdose penalty term. In addition to clinical considerations, such as the patient's medical history and past courses of radiation therapy, different organs usually exhibit different levels of sensitivity to radiation. For these reasons, we allow the penalties for each OAR to be scaled independently, allowing the planner to adjust the relative importance of meeting the dose targets for each structure separately.
We apply the penalty associated with each structure to every voxel in that structure, and the objective function of our treatment planning problem tallies these dose penalties over all voxels in a patient's anatomy.
Dose Constraints
In addition to dose penalties, we allow for hard constraints on the amount of radiation delivered to portions of the patient anatomy. For example, the clinician may only consider plans in which the spinal column receives a dose below a certain level because any more will increase the likelihood of injury beyond an acceptable limit. Basic constraints of this nature take the form of bounds on the mean, minimum, and maximum dose to a structure. More generally, bounds can be enforced on the dose to a fraction of the voxels in a structure. These dose-volume constraints restrict the relative volume that receives radiation beyond a particular threshold, giving the clinician precise control over the dose distribution. This is especially important when sparing OARs, since some organs are able to sustain high levels of uniform radiation, while others will fail unless the radiation is contained to a small fraction of the tissue.
Clinicians typically use a dose-volume histogram (DVH) to assess the quality of a treatment plan. For every structure, the DVH specifies the percentage of its volume that receives at least a certain dose. A point (x, y) on the curve indicates that y% of the total voxels in the structure receives a dose of at least x Gy. Ideally, we want our structures to receive exactly the prescribed dose throughout their volumes. If the prescription is d Gy, then our optimal DVH curve for the PTV is a step function with a drop at (d, 100), and our optimal DVH for each OAR exhibits a drop at (0, 100).
Dose constraints restrict the shape and location of points on the DVH curve. In Fig. 1 , a lower dose-volume constraint, D(90) ≥ 60, is represented by the right-facing arrow centered at (60, 90). This ensures that a minimum of 90% of the structure's volume receives at least 60 Gy, i.e., y ≥ 90 along the vertical line x = 60. The PTV's DVH curve is pushed rightward by this type of constraint. Similarly, an upper dose-volume constraint, D(33) ≤ 12, is labeled with a left-facing arrow at (12, 33), which pushes the OAR's DVH curve leftward, representing the restriction that y ≤ 33 along the line x = 12. Together, the DVH curves and their respective dose constraints enable the clinician to easily visualize trade-offs when formulating a treatment plan.
Convex Formulation
Consider a case with m voxels inside a patient volume and n candidate treatment beams. Our goal is to determine the beam intensities x ∈ R n + that deliver a vector of voxel doses y ∈ R m + , which meet a set of clinical objectives. We are given a case-specific dose influence with respect to x and y, where f : R m → R is a convex loss function chosen to penalize voxel doses based on the goals of the clinician. Here, the inequality on x is understood to be applied element-wise. In a typical case, a patient is prescribed a treatment plan that can be characterized by a vector of doses d ∈ R m + to each voxel. Our function f then penalizes the deviation of the calculated dose y from the prescribed dose d, taking into account the different structures inside a patient.
In our formulation, we consider a loss function
The parameters w − i and w + i are the non-negative weights on the underdose and overdose, respectively. This penalty structure is common in the literature [LC12] [CUT + 12] and provided the most efficient software implementation.
Prior to treatment planning, the m voxels in a patient volume are grouped into S distinct, non-overlapping sets representing the planning target volume (PTV), organs-at-risk (OARs), and generic non-target tissue (often labeled "body"). Each set V s contains all the voxel indices i within a corresponding internal structure with index s. Together, {V s } S 1 forms a partition of the patient volume, i.e., S 1 V s covers all voxel indices and V s 1 V s 2 = ∅ for s 1 = s 2 . We assume the indices are ordered such that s = 1, . . . , P ≤ S are targets and the rest non-targets.
For simplicity, we choose our voxel doses and penalties to be uniform within each structure. We let d s represent the prescribed dose, and w − s and w + s the underdose and overdose penalties for all voxels i ∈ V s . The loss function for our basic inverse planning problem is f (y) = S s=1 f s (y i ) where
A non-target structure s is always prescribed a dose of zero, and since y ≥ 0, its individual loss simplifies to f i (y i ) = w + s y i . Thus, its only contribution to the objective is through its total dose. An example of these loss functions is given in Fig. 2 . We can collapse the sum of non-target losses into a single linear term,
where c = (w
This formulation is closely related to quantile regression [DFV13] . In the latter, we minimize i φ(y i − v − d i ) with respect to (x, v) where
is the tilted 1 penalty with τ ∈ (0, 1). For our inverse planning problem, the residual r i := y i − v − d i can be interpreted as the difference between calculated and desired doses, allowing for a uniform dose offset v ∈ R within each structure. We rewrite our individual loss as
and the loss function becomes 
which implies τ s |V s | = |{i : r i < 0}|, i.e., in a given structure s, the τ s -quantile of optimal residuals is zero. Although our original loss does not include v, we can use this as a rule of thumb for selecting relative dose penalties (w
5 Dose Constraints
Percentile
A percentile constraint, otherwise known as a dose-volume constraint, bounds the dose delivered to a given percentile of a patient structure. This allows us to set a limit on the fraction of total voxels that are under-or overdosed with respect to a user-provided threshold. For clinicians, this provides a way to shape the dose-volume histogram directly rather than by searching through combinations of objective weights to achieve desired dose statistics. Given a structure s and dose vector y, let D s (p, y) represent the minimum dose delivered to p percent of all voxels in s, i.e., D s (p, y) is the greatest lower bound on the dose received by p% of the tissue.
To formalize this notion, we define an exact value count function v s : R m + × R + → Z + , which computes the total number of voxels i ∈ V s that receive a dose above b ∈ R + . Let
and our p-th percentile dose is
Observe that D s (p, y) ≥ 0 is finite and weakly decreasing in p.
Our goal is to bound D s (p, y). For example, we may want at least 30% of the voxels in structure s to receive a dose above 25 Gy; this is identical to D s (30, y) ≥ 25. Let < u be non-negative scalar values. An lower dose-volume constraint, D s (p, y) ≥ , requires the number of voxels in s that receive a dose above to be at least p% of the total voxels in the structure. Similarly, an upper dose-volume constraint, D s (p, y) ≤ u, requires the number of voxels i ∈ V s with a dose above u to be at most p% of voxels in V s , or equivalently, at least 100 − p% of the voxels to receive a dose under u. Thus, the inequalities
are equivalent, as are
In general, this is a hard combinatorial problem: the brute force approach for a single upper dose-volume constraint, for example, is to solve all |Vs| φ convex problems obtained by choosing subsets of φ = φ s (p) voxels to constrain below u, which is prohibitively large given the size of patient geometries.
Mean, Minimum, and Maximum
In a few special cases, we can set convex constraints on the dose. Let the average, minimum, and maximum dose delivered to all voxels in structure s be A lower bound b ∈ R + on the minimum dose is equivalent to requiring y i ≥ b for all i ∈ V s , and similarly for an upper bound on the maximum dose. Thus, we can enforce linear constraints on these dose statistics in our problem. Our non-convex formulation with exact dose-volume constraints is minimize f (y) subject to y = Ax x 0
where (x, y) are our variables, and for each structure s, we index the parameters of its dose-volume constraints with k = 1, . . . , K s .
Convex Restriction
To address the non-convexities in Prob. 1, we introduce a convex restriction that provides an effective heuristic for satisfying the dose-volume constraints. Our restricted constraint overestimates the number of voxels that are underdosed with respect to d by replacing the indicator g in v with a family of hinge loss functionŝ
parametrized by λ > 0, giving us a restricted value count for structure s of
, and if u ≤ 0, then g(u) = 0 ≤ĝ λ (u). Hence, g(u) ≤ĝ λ (u) for all u ∈ R and λ > 0 (Fig. 3) . Evaluating at u i = y i − b and summing over all voxels i ∈ V s , we obtain
An upper bound on the restricted value count at a given point thus ensures the exact value count is bounded above as well. We can guarantee our dose-volume constraints hold by enforcing specific limits onv. If v s (y, u; λ) ≤ φ s (p), then v s (y, u) ≤ φ s (p), and the upper dose-volume constraint, D s (p, y) ≤ u, is satisfied. Similarly,v s (−y, − ; λ) ≤ φ s (100 − p) implies that D s (p, y) ≤ . To simplify notation, we rewritev s (y, b; λ) ≤ φ as
Since λ > 0, we can divide both sides of the inequality by λ. Letting α := 1 λ and gathering all terms on the left-hand side, we obtain the inequality
The left-hand side of this inequality is a sum of convex functions of (α, y), and hence convex. Note that while λ was a parameter of our restricted value count function, α > 0 can be an optimization variable, since the left-hand term is jointly convex in α and y. Additionally, we can replace the constraint α > 0 with α ≥ 0 because when α = 0, the constraint simplifies 
where for every structure s, we index the parameters of its upper dose-volume constraints with k = 1, . . . , K
s , and its lower dose-volume constraints with k = 1, . . . , K ( ) s . We include a separate optimization variable, α s,k , in each dose-volume constraint to represent the inverse slope of its convex restriction and stack these variables in a vector α := (α ( ) , α (u) ). Optimizing over α in addition to (x, y) ensures we obtain the best hinge loss approximation to the value count function. The above formulation is a restriction of our original problem: if (x, y, α) is feasible for Prob. 2, then (x, y) is feasible for Prob. 1.
Refinements

Two-Pass Refinement
A solution (x * , y * , α * ) to Prob. 2 satisfies our restricted dose-volume constraints, so it is feasible for our original Prob. 1 with exact dose-volume constraints. However, since the convex restriction enforces an upper bound on the restricted value count functionv, the feasible set of Prob. 2 is a subset of the feasible set of Prob. 1, and (x * , y * ) may not be optimal for the latter. One way to improve our solution is to bound only the minimum number of voxels in each structure required to satisfy the dose-volume constraint. A good heuristic is to select those voxels i that receive a dose y * i , which satisfies the associated dose-volume bound by the largest margin, and re-solve the problem with the convex restriction replaced by bounds on just these voxels. The solution of this second pass, (x * * , y * * ), will achieve an objective value f (y * * ) ≤ f (y * ) while still satisfying our exact dose-volume constraints. To make this precise, consider the lower dose-volume constraint D s (p, y) ≥ . This is equivalent to y i ≥ for at least φ s (p) voxels in structure s. Given y * from our first pass optimization, we compute the margin ξ 
where the voxel subsets are indexed with k = 1, . . . , K (u) s for upper dose-volume constraints, and k = 1 . . . , K ( ) s for lower dose-volume constraints. We can warm start our solver at (x * , y * ) to speed up the second pass optimization.
Algorithm 6.1 Two-pass algorithm.
given a dose matrix A ∈ R m×n , a prescribed dose vector d ∈ R m , and a set of dose-volume constraints C. 
Dose Constraints with Slack
If our dose constraints are too strict, Prob. 2 may not have a solution. This can arise even if the feasible set for our original Prob. 1 is non-empty, since our convex restriction enforces more stringent bounds on the dose distribution. To ensure the first pass of our algorithm always supplies a solution, we introduce a slack variable δ ∈ R + to the bounds of each dose constraint, mapping lower bounds → ( − δ) and upper bounds u → (u + δ). This creates soft constraints that need not be met precisely by the solution. Our problem reformulated with restricted dose-volume constraints and slack is minimize f (y) subject to y = Ax x 0, α 0, δ 0
Note that δ := (δ (u) , δ ( ) ) is a variable in the optimization, and the value of each δ s,k indicates the amount (in units of delivered dose, e.g., Gy) by which each bound is weakened in the solution.
We can incorporate soft constraints into the two-pass algorithm as well. On the first pass, we solve Prob. 4 to obtain the optimal variables (x * , y * , α * ) and the optimal slacks δ * . Our margin for selecting Q s is now computed with respect to the slack bound, i.e., ξ * i = (y * i − + δ * ) for lower-volume dose constraints, and ξ * i = (u + δ * − y * i ) for upper dose-volume constraints. Finally, we weaken the bounds in Prob. 3 by δ * , giving us the reformulated second pass optimization with slack dose-volume constraints minimize f (y) subject to y = Ax x 0
Algorithm 6.2 Two-pass algorithm with slack.
given a dose matrix A ∈ R m×n , a prescribed dose vector d ∈ R m , and a set of dose-volume constraints C. 1. First pass. Obtain the solution (x * , y * , α * , δ * ) to Prob. 4. for each (δ * , , p, s) ∈ C do 2a. Compute margins. Calculate ξ * i = y * i − + δ * for all i ∈ V s . 2b. Sort margins. Sort {ξ * i } i∈Vs in ascending order to form a set ξ s . 2c. Identify voxel subset. Select the φ s (p) largest values ξ i ∈ ξ s and include their indices i in Q − s,k . end for for each (δ * , u, p, s) ∈ C do 3a. Compute margins. Calculate ξ * i = u + δ * − y * i for all i ∈ V s . 3b. Sort margins. Sort {ξ * i } i∈Vs in ascending order to form a set ξ s . 3c. Identify voxel subset. Select the φ s (100 − p) largest values ξ i ∈ ξ s and include their indices i in Q + s,k . end for 4. Second pass. Obtain the solution (x * * , y * * ) to Prob. 5 using (x * , y * ) as a warm start point.
Implementation
We implement our radiation treatment planning methodology with ConRad, a Python-embedded open-source software package based on the convex programming library, CVXPY [DB16] , using the convex solvers SCS [OCPB16] and ECOS [DCB13] . ConRad provides a simple, intuitive interface for ingesting patient data, constructing plans based on a clinical prescription, and visualizing the dose-volume histograms of the result. It allows the user to add dose constraints using syntax familiar to clinicians. Since ConRad is an ordinary Python library, it can be easily integrated into existing data processing pipelines.
The following code imports a prescription, solves for the optimal treatment plan without dose constraints, and plots the DVH curves for all the patient structures. The m × n dose-influence matrix A can be encoded as a NumPy ndarray or any of several sparse representations in Python. The m-length vector voxel labels enumerates the index of the assigned structure for each voxel in the patient volume.
import conrad # Construct the case with no dose constraints case = conrad.Case() case.prescription = "/Documents/prescriptions/rx_patient_01.yaml" case.physics.dose_matrix = A case.physics.voxel_labels = voxel_labels graphics = conrad.CasePlotter(case) # Solve with a single pass and no slack status, run = case.plan(solver="ECOS", use_slack=False, use_2pass=False) print("Problem feasible?:\n{}".format(status)) print("Dose summary:\n{}".format(case.dose_summary_string)) # Display color-coded plot of all DVH curves graphics.plot(run, show=True)
A Case object comprises Anatomy, Physics, Prescription and PlanningProblem objects. Prior to planning, the case's Anatomy and Physics objects must be built. The user can either build the case's Anatomy by adding structures programmatically (with data on each structure's name, index, identity as target/non-target, and desired dose) or by ingesting a prescription, which can be supplied as a Python dictionary or as a YAML or JSON file formatted for ConRad's parser. The minimum information required for the case's Physics object are the m × n dose matrix and a m-length vector of voxel labels. The case's Prescription object can be used to populate the Anatomy object or to keep track of clinical guidelines and objectives. It can also be left empty.
The case's PlanningProblem object builds and solves optimization problems based on the structures in the case anatomy and any constraints assigned to those structures. The PlanningProblem is not exposed to the user. Instead, users form a treatment plan by calling the case's plan() method, which returns a bool status indicating whether the specified problem was feasible, along with a RunRecord object that carries solver performance data, optimal variables, and DVH curves.
Before planning a case, the user can add, remove, or modify dose constraints to any structure. Thus, even when a case has an assigned prescription, the dose constraints attached to each structure in the case anatomy may differ from the constraints specified in the prescription. For example, the prescribed constraints may correspond to clinical guidelines, while the constraints used during planning may be chosen arbitrarily by the user to obtain plans with desirable dose properties.
After planning a case, users can plot the DVH curves, retrieve and print summaries of dose statistics for each structure, and when applicable, display a report of whether the current plan satisfies each constraint listed in the prescription. A case can be re-planned with different objective weights or dose constraints on any structure. The ConRad library provides a PlanningHistory object to retain and manage results from prior runs.
The following code adds a dose-volume constraint to the PTV from our previous case, allowing at most 20% of the PTV's voxels to receive more than 70 Gy. Algorithm 6.1 is then applied to obtain an optimal beam output. 
Examples
Basic Functionality
We present results illustrating the methods described in this paper: approximating dosevolume constraints via convex restrictions, two-pass refinement of plans with dose-volume constraints, and handling incompatible constraints with slack variables.
Problem Instances. We demonstrate the basic functionality on a head-and-neck case expressed as a VMAT aperture re-weighting problem. The case contains 360 apertures in four arcs, 270,000 voxels distributed across 17 planning structures, including the PTV treated to 66 Gy, two auxiliary targets treated to 60 Gy, several OARs, and generic body voxels.
To test the handling of dose-volume constraints, we plan the case with no dose constraints and then re-plan with a single dose-volume constraint applied to the PTV, namely D(20) ≤ 70 Gy. We run the two-pass algorithm and compare the plans obtained by applying restricted and exact versions of the aforementioned dose-volume constraint. Finally, we test the slack method by planning the case with two incompatible dose-volume constraints: D(98) ≥ 66 Gy on the PTV and D(20) ≤ 20 Gy on the spinal cord. We compare the results from enforcing the PTV constraint alone, both constraints without slack, and both constraints with slack allowed.
Computational Details. The size of the dose matrix passed from ConRad to the convex solvers in the backend varied depending on the dose constraints. When no minimum, maximum, or dose-volume constraints were applied to a non-target structure, the submatrix for that structure was replaced with a mean dose representation, thereby eliminating |V s | − 1 rows from the problem matrix. In particular, the matrix representing the full dose on the targets and mean dose for non-targets had dimensions 11,141 × 360, and the matrix including the full dose on the spinal cord was 15,000 × 360. The ConRad problem request was formulated as a convex program in CVXPY and passed to a GPU-based implementation of the convex solver SCS. Calculations were performed on a cluster with 32-core, 2.20 GHz Intel Xeon E5-4620 CPU and a nVidia TitanX graphics card.
Clinical Results: Dose-Volume Constraints. Fig. 4a depicts the DVH curves of the plan produced without any dose constraints. The PTV curve is shown in red with a dotted vertical line marking its prescribed dose of 66 Gy. The rest are DVHs for the OARs and generic body voxels. This solution to the unconstrained problem already gives a fairly good treatment plan. The DVH of the right cochlea and left parotid are pushed far left, so only 15-20% of their volume exceed 10 Gy, and almost no voxels are dosed above 30 Gy. The spinal cord receives somewhat more radiation, while the worst case is the brain with a slow, nearly linear drop-off to about 75 Gy.
The PTV curve begins to fall at 66 Gy, but does not reach zero until nearly 95 Gy. To reduce this overdosing, we add a dose-volume constraint that limits no more than 20% of the PTV to receive over 70 Gy, as indicated by the red, left-pointing arrow in Fig. 4b , and re-plan the case. The resulting DVH curves are depicted as solid lines in Fig. 4c , while the dashed curves represent the original plan. Under the new plan, the PTV curve has been pushed left at the arrow, and its drop-off around 66 Gy is steeper, meaning all voxel doses are closer to the prescription. Moreover, our OARs are minimally affected. We have reduced overdosing to the PTV without significantly increasing radiation to other organs.
Clinical Results: Two-Pass Algorithm. A close inspection of Fig. 4c reveals a gap between the PTV curve and the DVH constraint arrow. This is due to the conservative nature of the convex restriction, which overestimates the number of voxel violations. We can eliminate this gap and improve our overall objective with the two-pass algorithm. Fig.  5a shows the plan from the first pass. There is a margin of about 0.5 Gy between the PTV curve and arrow, meaning at most 20% of the PTV receives over 69.5 Gy, a more restrictive solution than required by our constraint D(20) ≤ 70 Gy. This margin disappears in Fig. 5b . Here, the dashed lines depict the first pass solution, and the solid lines come from the second pass. The second pass PTV curve falls precisely on the center of the left-facing arrow, meaning the dose-volume constraint is tight. In addition, the DVH curves for the right cochlea and left parotid have shifted leftward, indicating they now receive less radiation. By replacing our convex restriction with exact voxel constraints, we are able to make gains in our OAR clinical objectives while still fulfilling the DVH constraint.
Clinical Results: Constraints with Slack. So far, we have specified only one dose constraint. A problem may become infeasible when multiple constraints are enforced, either because the user-supplied bounds are too extreme or the convex restriction too severe in its overestimation of the voxel count. In such cases, we can still produce a plan that approximately conforms to the desired specifications by enabling slack constraints. Fig. 6b , and re-plan the case, the optimizer tells us that the problem is infeasible. It is impossible to meet both (convex restricted) dose-volume constraints exactly. We thus re-plan allowing for slack bounds on these constraints. The resulting DVH curves are plotted in Fig. 6c with dotted lines representing the original plan and solid lines for the new plan. The PTV constraint has been relaxed by about 3 Gy, as symbolized by the red arrow shifting left behind the solid red curve to (98, 63). This small concession allows us to satisfy the OAR constraint by a wide margin. Approximately 226 million (roughly 10.6%) of the entries in the dose matrix are non-zero.
In our experiments, we used only a subset of 10,000 beamlets from this matrix. We plan the case with the prescription detailed in Table 1 , which is adapted from the QUANTEC guidelines [MYJ + 10]. The computational details are the same as in the headand-neck case. As before, we analyze the results from a single pass and two-pass algorithm with and without slack allowed. We then re-plan the case with only the PTV dose constraint and compare its runtime and OAR overdose to the plans produced from the full prescription.
Timing Results. Our algorithm produces a plan that satisfies all dose constraints using a single pass with slack enabled. The optimization finishes in 426.9 seconds, about 2.5x the runtime of the head-and-neck case. A second pass takes approximately the same amount of time and does not result in significantly larger constraint margins. The presence or absence of slack also has little impact on the runtime, which varies by at most 7 seconds.
If we drop all except the mean dose constraints, the problem collapses into a linear program, greatly decreasing the runtime. The size of this reduction depends on the characteristics of the affected structures and the dose influence matrix. For example, in the head-and-neck case, the runtime falls by 87% to a mere 24 seconds. Conversely, when adding dose-volume constraints, the initial constraint on a structure will have a greater impact on runtime than subsequent additions.
Conclusion
We have developed a convex formulation for the FMO problem that incorporates dose-volume constraints. Our model replaces each exact dose-volume constraint with a convex restriction, which overestimates the number of voxels that violate the clinician's desired threshold. This allows us to solve the problem quickly and efficiently using standard convex optimization algorithms. We also introduce two refinements: a two-pass algorithm and a model with slack. In the former, we improve our initial solution by re-optimizing with the restrictions replaced by bounds on a subset of voxels, enabling us to achieve a better objective that still satisfies the dose-volume constraints. The latter allows for soft bounds and is useful if the restricted constraints render the problem infeasible. We demonstrate the efficacy of our method on a VMAT head-and-neck case and a prostate case. Our algorithm consistently produces good treatment plans that fulfill all dose constraints when feasible. In problems with infeasible constraints, we are able to generate plans that minimize the dose violation while taking into account clinical goals, allowing clinicians to easily visualize trade-offs and select the plan that is best for the patient.
A variety of extensions to our two-pass algorithm are possible. For instance, we could rewrite the original problem as a mixed-integer linear program and use the solution of the convex restriction to warm start a branch-and-bound solver. More broadly, we could apply this starting point to accelerate any number of iterative approaches in the literature. Dosevolume constraints are often assigned different priorities in practice, and our algorithm may be easily adapted to accommodate such user-defined preferences, either through new penalties, changes in the slack, or additional passes that impose the constraints in a lexicographic order. These hybrid methods, which combine convex approximations with non-convex solution methods, offer an important avenue for future research.
